Rapid Micro Biosystems, Inc. Class A Common Stock
RPID
RPID: Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
moreShow RPID Financials
Recent trades of RPID by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RPID's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Microbiological growth media and methods of using the same Aug. 22, 2023
-
Patent Title: Cell culturing device May. 09, 2023
-
Patent Title: Rapid detection of replicating cells Nov. 15, 2022
-
Patent Title: Cassette for sterility testing Oct. 13, 2020
-
Patent Title: Microbiological growth media and methods of using the same Oct. 06, 2020
-
Patent Title: Cell culturing device Sep. 10, 2019
-
Patent Title: Cassette for sterility testing Aug. 29, 2017
-
Patent Title: Rapid detection of replicating cells Mar. 22, 2016
-
Patent Title: Rapid detection of replicating cells Jul. 28, 2015
-
Patent Title: Cassette containing growth medium Jun. 16, 2015
Federal grants, loans, and purchases
Followers on RPID's company Twitter account
Number of mentions of RPID in WallStreetBets Daily Discussion
Recent insights relating to RPID
Recent picks made for RPID stock on CNBC
ETFs with the largest estimated holdings in RPID
Flights by private jets registered to RPID